Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (331-340 of 426) with videos related to

Pageof 43
Sort By:
Plos One|December 17, 2008
Non-natural and photo-reactive amino acids as biochemical probes of immune functionMarta Gómez-Nuñez, Kurtis J Haro, Tao Dao, et al.
Research Square|May 22, 2023
Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1Sung Soo Mun, Leila Peraro, Jeremy Meyerberg, et al.
EMBO Molecular Medicine|April 14, 2026
Targeted cellular micropharmacies deliver therapeutic agents to the brainManish Malviya, Subha Baniya, Eitan Wong, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expressionD A Scheinberg, D J Straus, S D Yeh, et al.
Plos One|May 23, 2025
A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activityKeifer G Kurtz, Irina Lebedeva, Stephanie A Pierre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Journal of Leukocyte Biology|June 16, 2004
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteinsAnja Moldenhauer, Richard C Frank, Javier Pinilla-Ibarz, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Pageof 43

Showing results (331-340 of 426) with videos related to

Sort By:
Pageof 43
Plos One|December 17, 2008
Non-natural and photo-reactive amino acids as biochemical probes of immune functionMarta Gómez-Nuñez, Kurtis J Haro, Tao Dao, et al.
Research Square|May 22, 2023
Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1Sung Soo Mun, Leila Peraro, Jeremy Meyerberg, et al.
EMBO Molecular Medicine|April 14, 2026
Targeted cellular micropharmacies deliver therapeutic agents to the brainManish Malviya, Subha Baniya, Eitan Wong, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expressionD A Scheinberg, D J Straus, S D Yeh, et al.
Plos One|May 23, 2025
A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activityKeifer G Kurtz, Irina Lebedeva, Stephanie A Pierre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Journal of Leukocyte Biology|June 16, 2004
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteinsAnja Moldenhauer, Richard C Frank, Javier Pinilla-Ibarz, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Pageof 43